Controversial simulation creates galaxies without using dark matter – Astronomy Magazine

Dark matter dogma

Pavel Kroupa, an astrophysicist at the University of Bonn in Germany, is among these standard model critics. According to him, dark matter has become dogma. He cites a handful of real-world properties seen in galaxies that dont make sense with dark matter. And he also questions many fundamental and widely-accepted aspects of modern cosmology, from the idea that galaxies can merge to whether the Cosmic Microwave Background is really evidence of the Big Bang.

Kroupa has spent the past two decades pushing MOND, an alternative theory of the universe. Scientists who support this model believe that the most puzzling aspects of the cosmos the ones that led astronomers to discover dark matter and dark energy can actually be explained with slight modifications to Newtons laws describing gravity.

But to convince the larger scientific community, contrarians like Kroupa have to show that MOND can actually recreate our universe while also explaining the same mysteries that first led astronomers to embrace the dark side. And until now, computer simulations using MOND have failed to build virtual galaxies that look like the real ones we see today.

So, other scientists skeptical of the standard model see this new study as a potential milestone.

This is clearly an important study, because MOND was often criticized for not being able to describe galaxy formation in the same successful way as models based on dark matter, says University of Amsterdam theoretical physicist Erik Verlinde, a prominent dark matter critic who was not involved in the research.

Excerpt from:

Controversial simulation creates galaxies without using dark matter - Astronomy Magazine

How Interferometry Works, and Why it’s so Powerful for Astronomy – Universe Today

When astronomers talk about an optical telescope, they often mention the size of its mirror. Thats because the larger your mirror, the sharper your view of the heavens can be. Its known as resolving power, and it is due to a property of light known as diffraction. When light passes through an opening, such as the opening of the telescope, it will tend to spread out or diffract. The smaller the opening, the more the light spreads making your image more blurry. This is why larger telescopes can capture a sharper image than smaller ones.

Diffraction doesnt just depend on the size of your telescope, it also depends on the wavelength of light you observe. The longer the wavelength, the more light diffracts for a given opening size. The wavelength of visible light is very small, less than a millionth of a meter in length. But radio light has a wavelength that is a thousand times longer. If you want to capture images as sharp as those of optical telescopes, you need a radio telescope that is a thousand times larger than an optical one. Fortunately, we can build radio telescopes this large thanks to a technique known as interferometry.

To build a high-resolution radio telescope, you cant simply build a huge radio dish. You would need a dish more than 10 kilometers across. Even the largest radio dish, Chinas FAST telescope, is only 500 meters across. So instead of building a single large dish, you build dozens or hundreds of smaller dishes that can work together. It is a bit like using only parts of a great big mirror instead of the whole thing. If you did this with an optical telescope your image wouldnt be as bright, but it would be almost as sharp.

But its not as simple as building lots of little antenna dishes. With a single telescope, the light from a distant object enters the telescope and is focused by the mirror or lens onto a detector. The light that left the object at the same time reaches the detector at the same time, so your image is in sync. When you have an array of radio dishes, each with their own detector, the light from your object will reach some antenna detectors sooner than others. If you just combined all your data you would have a jumbled mess. This is where interferometry comes in.

Each antenna in your array observes the same object, and as they do they each mark the time of the observation very precisely. This way you have dozens or hundreds of streams of data, each with unique timestamps. From the timestamps, you can put all the data back in sync. If you know that dish B gets a single 2 microseconds after dish A, you know signal B has to be shifted forward 2 microseconds to be in sync.

The math for this gets really complicated. In order for interferometry to work, you have to know the time difference between each pair of antenna dishes. For 5 dishes thats 15 pairs. But the VLA has 26 active dishes or 325 pairs. ALMA has 66 dishes, which makes for 2,145 pairs. Not only that, as the Earth rotates the direction of your object shifts relative to the antenna dishes, which means the time between the signals changes as you make observations. You have to keep track of all of it in order to correlate the signals. This is done with a specialized supercomputer known as a correlator. It is specifically designed to do this one computation. It is the correlator that lets dozens of antenna dishes act as a single telescope.

It has taken decades to refine and improve radio interferometry, but it has become a common tool for radio astronomy. From the inauguration of the VLA in 1980 to the first light of ALMA in 2013, interferometry has given us extraordinarily high-resolution images. The technique is now so powerful that it can be used to connect telescopes all over the world.

In 2009 radio observatories across the world agreed to work together on an ambitious project. They used interferometry to combine their telescopes to create a virtual telescope as large as a planet. It is known as the Event Horizon Telescope, and in 2019 it gave us our first image of a black hole.

With teamwork and interferometry, we can now study one of the most mysterious and extreme objects in the universe.

Like Loading...

See more here:

How Interferometry Works, and Why it's so Powerful for Astronomy - Universe Today

Heather Couper, 19492020 – Astronomy Now Online

Photo: Heather Couper.

Heather Couper, one of the UKs most prolific astronomy broadcasters and writers, who inspired many to take up stargazing, has died at the age of 70.

Couper came to prominence in the 1980s, writing and presenting two landmark Channel 4 television series, The Planets (1985) and The Stars (1988), as well as The Neptune Encounter (1989) for ITV, which was made under the auspices of her production company Pioneer Productions, which she founded with her long-time friend and collaborator Nigel Henbest and director Stuart Carter. She also narrated Pioneer Productions award-winning Channel 4 documentary Electric Skies (1994), about lightning, as well as the ten-part Raging Planet series (1997) and Space Shuttle: Human Time Bomb? (2003). Couper has also presented numerous radio documentaries, including Radio Fours Cosmic Quest about the history of astronomy, and the long-running Seeing Stars on the BBC World Service, presented alongside Nigel Henbest.

She graduated from the University of Leicester with a BSc in Astronomy and Physics, although by her own admission in an interview for The Independent (for whom she was also a columnist), she was not a model student at school or university. However, it was her passion for astronomy, having witnessed a green meteor as a child, that spurred her on. After leaving research half way through her PhD studies at The University of Oxford, she joined the planetarium at the Royal Observatory, Greenwich as Senior Lecturer, where she remained until 1983 when she departed to pursue her media career.

Couper helped break down boundaries for women in astronomy. The year after leaving Greenwich she was elected President of the British Astronomical Association the first woman, and the second youngest person (at the age of 35), to hold the position. Between 1987 and 1989 she held the position of President for what is now known as The Society for Popular Astronomy. She was one of the speakers at the very first European AstroFest conference in 1992.

In 1993, she became Professor of Astronomy at Gresham College in London the first female professor at Gresham in its 400-year history (Carolin Crawford and Katherine Blundell have since followed in her footsteps), where she gave public talks on astronomy for three years. And of course, as one of the public faces of astronomy on television, she inspired many girls, as well as boys (including a certain Editor of Astronomy Now magazine), to take an interest in astronomy.

She was also a prolific writer alongside Nigel Henbest, with dozens of titles spanning forty years, including companions to her TV series The Planets and The Stars, The Secret Life of Space, and her most recent books including Philips 2020 Stargazing Month by Month and The Universe Explained: A Cosmic Q&A, published by Firefly.

In 1994 Couper was elected to serve on the Millennium Commission, which dished out money raised by the National Lottery to good causes. She remained on the commission until it closed in 2009, and in 2007 she was awarded a CBE by the Queen for her work on both the commission and her life-long mission to promote astronomy.

Couper also has an asteroid named after her, asteroid 3922 Heather.

She died in her sleep at Stoke Mandeville Hospital in Buckinghamshire, on 19 February 2020, following a short illness.

Read more here:

Heather Couper, 19492020 - Astronomy Now Online

Star Betelgeuse’s mysterious dimming has the attention of UA astronomer – Arizona Public Media

A University of Arizona astronomer has his eye on a mysteriously dimming star in outer space.

Narsi Anugu is a postdoctoral scholar at the UA studying interstellar space. He is focusing on the star Betelgeuse, 642.5 light years from earth. The star's light has been dimming for the past several months, and some scientists speculate it is on the verge of exploding, or going supernova. Anugu thinks if that happens, the resulting phenomenon will create a boon for space science.

This will boost astronomy, clear up many questions about whether astronomy is interesting, and increase funding," he said. "Every astronomer would love to see that.

Betelgeuse is seen from Earth as part of the popular constellation Orion, the hunter. The star marks the shoulder of the hunter on the left side of the figure to a viewer from Earth. Scientists say whenever Betelgeuse explodes, it will be visible in Earth's daylight sky and would be bright enough to cast shadows at night. But they cautiously add the event might not happen for another 100,000 years.

Read more here:

Star Betelgeuse's mysterious dimming has the attention of UA astronomer - Arizona Public Media

Heather Couper: Astronomer who brought the stars to a wide audience – The Independent

Heather Couper, who has died aged 70, was just seven when she spotted what looked like a bright-green meteor in the sky. Her airline pilot father told her there was no such thing, but newspapers subsequently reported on a shooting star and she set her heart on becoming an astronomer.

At the age of 16, she wrote to Patrick Moore, whose television programme The Sky at Night inspired viewers to look to the heavens, and askedwhether being female might hamper her ambitions. Being a girl is no problem at all, Moore replied.

So she carved out a career as an astronomer and, from 1978 to 1984, while lecturing on the subject, was often seen as a guest or co-presenter on The Sky at Night.

Sharing the full story, not just the headlines

She also succeeded Moore as president of the British Astronomical Association (1984-86), the first woman in the role one previously occupied by worthy old gentlemen who preferred to remain discreetly out of the public eye, aside from Moore, according to New Scientist magazine at the time.

With the ability to popularise astronomy for a wide audience, Couper went freelance to become a television presenter and producer.

She and fellow astronomer Terence Murtagh hosted the 1981 childrens series Heavens Above. The wonders of the universe was the pairs theme as they examined the planets in the solar system.

Film shot by the American Viking and Voyager space probes vividly brought their words to life. There were also enlightening items such as an imaginary trip to Earth from a planet in the Andromeda galaxy.

Moving on to TV for grown-ups, Couper wrote and presented two of Channel 4s early science successes.

Mars, until quite recently, held out the promise of life, but now we know its a sun-bleached, sterile world, was typical of her candid assessments of the subjects in The Planets (1985).

Couper with her collaborator and lifelong companion Nigel Henbest: their Stargazing column has run in The Independent since 1987(Hencoup Enterprises/PA)

The Stars (1988) was a natural follow-up. Stars were the sparks that rescued our universe from becoming an ever-cooling and expanding vastness, explained Couper as she launched the series with the potentially worrying observation that galaxies giant, rotating star cities like our own Milky Way had been moving fatally further apart. The gravity of stars kept the universe alive, she said.

Only the best news in your inbox

Couper also presented the marathon30-part radio series Cosmic Quest (2008), charting the rise of science by tracing the progress of astronomy and astronomers such as Ptolemy, Copernicus and Halley through the ages.

She said her career highlight was being the astronomer aboard Concorde in 1986 showing Halleys Comet to passengers on a flight to New Zealand.

In 1999, on her 50th birthday, Asteroid 3922 Heather, discovered 28 years earlier, was named after her.

Heather Anita Couper was born in Wallasey, Cheshire, in 1949 to Anita (nee Taylor) and George Couper, and brought up in Ruislip, Middlesex.

On leaving St Marys Grammar School, Northwood (now Haydon School), she spent two years as a management trainee with Topshop, then owned by the fashion retailer Peter Robinson.

Joining a local astronomical society reignited her interest in astronomy and she began to realise her dream by working as a research assistant at Cambridge Observatories (1969-70), before graduating in astrophysics from Leicester University in 1973.

Couper became a researcher in Oxford Universitys astrophysics department and, from 1977 to 1983, a lecturer at the Greenwich Planetarium in the Royal Observatory.

Couper was author or co-author of more than 40 books (Hencoup Enterprises/PA)

She then concentrated on broadcasting. Nigel Henbest, who became her lifelong companion after they met as students at Leicester University, worked as a researcher and consultant on The Planets and The Stars, then formed Pioneer Productions in 1988 with Couper and TV director Stuart Carter to make science programmes for global markets.

For Pioneer, she presented The Neptune Encounter (1989), about Nasa spacecraft Voyager 2s flyby of the planet, and Space Shuttle Discovery (1993), as well as writing and narrating Space Shuttle: Human Time Bomb? (2003), investigating the design flaws and cost-cutting measures leading to the disintegration of the returning shuttle Columbia.

As a producer, Couper made Wonders of Weather (1996), Black Holes (1997) and Universe: Beyond the Millennium (1999), as well as episodes of Horizon and Equinox.

Her many radio series as a presenter included Starwatch (1996) and Worlds Beyond (2004-5). She was an author of more than 40 books, many with Henbest, and since 1987 the pair wrote The Independents monthly Stargazing column.

Couper was the first female professor of astronomy at Gresham College (1993-96) and, from 1994 to 2009, served as one of the millennium commissioners responsible for allocating 500m to public science projects. She was made a CBE in 2007.

Heather Couper, astronomer, born 2 June 1949, died 19 February 2020

Link:

Heather Couper: Astronomer who brought the stars to a wide audience - The Independent

Molecular oxygen has been spotted beyond the Milky Way for the first time – Science News

For the first time, astronomers have found molecular oxygen thesame gas humans need to breathe in a galaxy outside the Milky Way.

Oxygen is the third most common element in the cosmos, after hydrogen andhelium. So astronomers once thought molecular oxygen, O2, would becommon in the space between the stars. But despite repeated searches, no onehad ever seen molecular oxygen beyond our galaxy until now.

Junzhi Wang, an astronomer at Shanghai Astronomical Observatory in China, andhis colleagues spotted the molecules calling card in a galaxy named Markarian231. Lying 560 million light-years away in the constellation Ursa Major, Markarian 231is the nearest galaxy to Earth that contains a quasar, where gaswhirls around a supermassive black hole and gets so hot that it glowsbrilliantly.(SN: 8/31/15).

Using radio telescopes in Spain and France, the astronomers saw radiation at awavelength of 2.52 millimeters, a signatureof O2s presence, the team reports in the Feb. 1 Astrophysical Journal.This is the first detection of molecular oxygen in an extragalactic object,Wang says.

Its also the most molecular oxygen ever seen outside the solarsystem. Previously, astronomers had seen the molecule in just two star-formingclouds within the Milky Way, the Orion Nebula and the Rho Ophiuchicloud(SN: 1/28/20). Astronomers think the shortage of interstellar O2 isdue to oxygen atoms and water molecules freezing onto dust grains, locking up theoxygen. In these stellar nurseries, though, shocks from bright newborn starscan rip water ice from the dust, freeing oxygen atoms to find each other andform molecules.

But even in the Orion Nebula, molecular oxygen is rare, withhydrogen molecules outnumbering oxygen molecules a million to one. Hydrogenalso dominates in Markarian 231. But molecular oxygen spans the outskirts ofthe galactic disk at abundances more than 100 times greater than in the OrionNebula.

Thats very high, says Gary Melnick, an astrophysicist at theHarvard-Smithsonian Center for Astrophysics in Cambridge, Mass., who was notinvolved in the work. There is no known explanation for an abundance of molecularoxygen that high. To confirm that the radiation really arises from O2,Melnick says the observers should look for a second wavelength from themolecule.

That wont be easy, Wang says, because other molecules also emit radiation atthose wavelengths. To shore up the case for O2, the scientists wentthrough the many molecules that give off wavelengths similar to the onedetected and found that nobody had ever seen any of those molecules in space except for O2. It is guilt by elimination, if you will, says teammember Paul Goldsmith, an astronomer at the Jet Propulsion Laboratory inPasadena, Calif.One possibleexplanation for all the O2 is that Markarian 231 goes through a morevigorous version of the Orion Nebulas oxygen-forming process. The galaxy is aprolific star factory, spawning new stars 100 times as fast as the Milky Wayand spewing out 700 solar masses of gas per year. High-speed gas from thegalaxys center may slam into gas in the disk, shaking water ice from dust grainsso that molecular oxygen can form.

In turn, that oxygen couldkeep the galaxy hyperactive: Radiation the molecule emits helps cool thegas so that some of it can collapse and create even more new stars in thegalaxy.

Read the original here:

Molecular oxygen has been spotted beyond the Milky Way for the first time - Science News

How a Single Image Taken in 1995 Revolutionized Astronomy – Fstoppers

The Hubble Space Telescope has been one of the most important scientific instruments to have ever been deployed, and it has provided countless advancements to the fields of astronomy and cosmology. This fascinating video takes a look at one of the earliest and most important images the telescope took and how it continues to impact science even 25 years later.

Coming to you from Vox, this excellent video details the 1995 Hubble Space Telescope deep field observation and how it vastly changed our knowledge ofthe universe and even how astronomers work with data. The two things I have always loved about these images are the age of the light we are looking at and the sheer vastness contained in such a tiny spec (relatively speaking) of space. The image shows somegalaxies that are over 12 billion years old, meaning they were around at a relatively young time for the universe, giving us amazing insight into its history. It also boggles my mind just how much is contained in each of those little blips of light. Entire galaxies with millions orbillions of stars reside in those seemingly innocuous specs, reinforcing how the universe operates on scales of size that are truly beyond our own intuitive grasp. Check out the video above for the full story.

Read the original here:

How a Single Image Taken in 1995 Revolutionized Astronomy - Fstoppers

These 60 Hyderabad kids are falling in love with astronomy at BMBSC. Do you know how? – EdexLive

All those students who aim to reach for the stars, quite literally, to pursue a career inAstronomyor just want to understand the cosmos better are a part of the ongoingWinter School onAstronomybeing conducted atBM Birla Science Centrein Hyderabad from February 16 to 21. The fourth edition of the five-day camp is being attended by 60 space enthusiasts selected carefully from over 700 applicants. "We just want to offer a platform where students get to know about high-end Science and what's actually happening in the field," saysPranav Sharma, Scientific Officer and Curator of the Space Museum. What this school does is effectively combine talks with hands-on workshops which gives the participants, who are senior undergraduate and postgraduate students, a clear path that they could take towardsAstronomy. Students are participating from across India and care was taken to ensure a gender-balanced ratio; students from Tier II and III cities were given preference.

Another point to note about the school is that students from diverse backgrounds and an inclination towardsAstronomywere selected. "Interdisciplinary studies need to be encouraged and students should understand that disciplines don't have any borders," says the three-time winner of the REX Karmaveer Chakra Award. Especially with the advent of Computer Science and Big Data, everything has changed, he asserts.

What was new this year is a talk and workshop on Computational Astrophysics by none other than Prof Ashish Mahabal, anastronomerand Lead Computational and Data Scientist at the California Institute of Technology. In fact, this was what this year's session started with on February 16. On February 17 was a talk on Big Data and Deep Learning inAstronomyand Biology by Prof Ajit Kembhavi, Professor Emeritus at the Inter-University Centre forAstronomyand Astrophysics, Pune, that was also the need of the hour, as per the 27-year-old. On the last day, a talk on 'New Insights and Challenges in Probing our Nearest Star: The Sun' by Prof Siraj Hasan, former Director of the Indian Institute of Astrophysics, Bengaluru, will enthrallthe participants.

The response, needless to say, is exceptional. Many discussions, including off-stage ones, are going on wherein experts from academia and students were seen engrossed in intense talks. "This offered a great chance for the senior academicians to interact with students, something that they don't get to do on a regular basis," says the Agra-born curator.Pranav asserts that the scope ofAstronomyin India is expanding and students can make the most of it if they wish. "With projects like the CERN collaboration and the Thirty Meter Telescope that India has taken on, youngsters interested in the field have enough to look forward to," he says and concludes.

Other interesting sessions:- The Exciting World of Neutrinos by Prof Sanjib Agarwalla from Institute of Physics, Bhubaneswar- Exhibition on various sizes of kytoons (kite balloons)- The Romance ofAstronomyby Pranav Sharma, Curator of the Space Museum- Twenty Five Years of Exoplanets: What Have We Learned So Far? by Prof Manoj Puravankara, TIFR, Mumbai

Scenes from the previous schools

For more on them, visit: astrowin19.wixsite.com/astrowin20

Read the original post:

These 60 Hyderabad kids are falling in love with astronomy at BMBSC. Do you know how? - EdexLive

Look up: Astronomical event on the way – WOODTV.com

GRAND RAPIDS, Mich. (WOOD) Early Tuesday morning, a neatastronomical event will occur. Across the United States, people will be able towatch the planet Mars disappear behind the moon.

Unfortunately, its looking cloudy in West Michigan, so we wonthave the best view here. Our neighbors across the country with clearerconditions will be able to see Mars disappear behind the lit side of the moon thenreappear on the dark side around an hour later.

In Grand Rapids, Mars will disappear behind the moon around 7:12a.m., just before sunrise. It will reappear after sunrise around 8:38 a.m. Ifskies were clear, a telescope would likely still be needed to view the phenomenondue to the lighter conditions. The western United States will have a betterchance of seeing the occultation with the naked eye.

An occultation of a planet is not rare, but you have to be on theright spot of the globe to see it happen. Almost all the United States will beable to see this occultation of Mars (weather permitting) with the onlyexceptions being Hawaii, Alaska and a small portion of the PacificNorthwest.

We have a better chance of clearer conditions early Wednesdaymorning and early Thursday morning. In the pre-dawn hours on Wednesday, look tothe southeast toward the moon. You should be able to see Jupiter to the left ofthe moon.

Both Saturn and Jupiter will be close to the moon on Thursday morning. The moon will be to the lower right of Saturn and Jupiter will be to the upper right of the moon. Again, youll want to look toward the southeast at dawn.

More here:

Look up: Astronomical event on the way - WOODTV.com

Astronomers look to preserve the night sky as thousands of satellites set to launch – CBC.ca

The potential launch of tens of thousands of satellitesis a serious threat to astronomy, according to the International Astronomical Union (IAU). Now, it's trying to find solutions.

The announcement came just days before SpaceX launched an additional 60 of its Starlink satellites.

Such "constellations" any collection of artificial satellites are already in wide use,powering the GPS in our cars and cellphones, for instance. But it's the massive number yet to come that has astronomers around the world deeply concerned.

"We are used to some satellites crossing the night sky, but now we're talking about thousands, some that would be bright enough to seewith the human eye," said Piero Benvenuti, an adviser at the executive committee of the IAU, which has more than 13,000 members worldwide.

In all, SpaceXplans to launch as many as 42,000 satellites, and it's not theonly one. Amazon plans to launch roughly 3,200 satellites, and OneWeb's 650 satellites. Canada also plans to launch 300 Telesat satellites.

The goal of Starlink isto bring internet connectivity to every part of the world, a goal similar to OneWeb's.

And while astronomers agree that goal is a practical one, they are concerned over not only the loss of the night sky, which is already under threat due to light pollution, but also to large-scale and very expensive observatories, like the $1 billion US, 8.4-metre, ground-based Large Synoptic Survey Telescope.

There are more and more of these all-sky surveys being put into place. Instead of looking at a small patch of sky, they scan large swaths. But moving satellites create long streaks of light in the images collected.

"Apart from their naked-eye visibility, it is estimated that the trails of the constellation satellites will be bright enough to saturate modern detectors on large telescopes," the IAU statement said. "Wide-field scientific astronomical observations will therefore be severely affected."

Reports of the visibility of a "train" of Starlink satellites began lastMay, shortly after the first batch of 60 were launched. Astronomers, both professional and amateur, posted videosand photos of the long streak of satellites dotting the night sky.

Then, in December, more satellites were launched.

But while the threat may be most felt by professionals, the IAU statement noted, "The appearance of the pristine night sky, particularly when observed from dark sites, will nevertheless be altered, because the new satellites could be significantly brighter than existing orbiting man-made objects."

As a result, the IAU, as well as other organizations like the American Astronomical Society, sought out professional astronomers to run simulations showing what would happen with tens of thousands of satellites in orbit around Earth. Thehope was to not only better understand the consequencesbut also head toward some solutions.

They found that, using an exampleof 25,000 satellites in low-Earth orbit which ranges from 160 to 2,000 kilometres above Earth and with orbits between 84 and 127 minutes at any given point, satellites above the horizon could number from 1,500 toa few thousand.

Some other notable findings:

Benvenuti is keen for more researchin order to better understand what the effects of tens of thousands of satellites could be.Right now, he said, astronomers are working with SpaceX in an effort to reduce their reflectivity called albedo and trying to work with other companies as well.

Connie Walker, an astronomer and president of the Commission B7, which is involved in the IAUconstellation analysis, saidthe idea is to find a solution suitable for everyone.

"It's going to be a long process, and I think to some extent, the various companies producing these satellite constellations are willing to try to come up with some solutions," she said. Some of the ideas being examined, she said, are changes to thecoatings of the satellites and changes to software to help observatories avoid, or compensate for, albedo.

But, she said, there is unlikely to be one quick-fix that will check off all the boxes.

The launch of satellite constellations and their consequences have largely taken the astronomical community by surprise. One of the problems is that there is no regulation surrounding the albedo of an object in orbit.

But that might change.

WATCH: Atrain of Starlink satellites crosses the sky (on theright)

The IAU plans to bring the issue to the UN Committee on the Peaceful Uses of Outer Space (COPUOS) in the coming months. They also plan to include the issue of constellations and their threat to science inthe program of the Conference on Dark and Quiet Skies for Science and Society, held by the IAU, the United Nations Office for Outer Space Affairs and the Government of Spain in October.

"We don't want to stop the progress of having this G5 interconnectivity," Benvenuti said. "But one has to consider the implications that you're creating on the environment, and in particularthe night sky."

And, he added, "We don't want to cry wolf and say it's a disaster and you can't do astronomy anymore."

But astronomy is more than just looking up at the night sky, admiring the stars or photographing them. It's about advancing knowledge and even technologies.

"The progress that we've made in the last 100 years It's absolutely astonishing how much we've learned because of astronomical observations," he said. "When you use your GPS, you apply Einstein's relativity, otherwise you wouldn't know where you are. People tend to forget about this."

Read the original post:

Astronomers look to preserve the night sky as thousands of satellites set to launch - CBC.ca

SETI and other alien-hunting strategies are dealing with new tools and new troubles – GeekWire

Two PANOSETI telescopes are installed in the recently renovated Astrograph Dome at the Lick Observatory in California. PANOSETI will use a configuration of many SETI telescopes to allow simultaneous monitoring of the entire observable sky. ( Laurie Hatch Photo via UCSD)

The search for extraterrestrial intelligence, better known as SETI, is taking advantage of a widening array of strategies ranging from sophisticated laser searches, to a new type of wide-angle optical observatory, to arrangements to conduct the search simultaneously with other scientific efforts.

But new technologies are also bringing new challenges: For example, how will radio astronomers deal with the noise created by a fast-growing number of satellites in low Earth orbit?

The technological pluses and minuses for the SETI quest, and for other strategies aimed at detecting life beyond our solar system, took the spotlight in Seattle last weekend during a session presented at the annual meeting of the American Association for the Advancement of Science.

Were bringing a Silicon Valley approach to the search for advanced life, said Andrew Siemion, whos the director of the Berkeley SETI Research Center as well as principal investigator for the 10-year, $100 million Breakthrough Listen project. Usually I add that were trying to bring the good parts of Silicon Valley to the search, not necessarily some of the bad parts.

Siemion focused on the good parts, including the public release of the second big batch of radio data from Breakthrough Listen. That campaign got its start nearly five years ago with a high-profile kickoff from Israeli-Russian tech billionaire Yuri Milner and the late British physicist Stephen Hawking.

Since then, Breakthrough Listen has forged partnerships with radio telescope arrays around the world most recently with the National Radio Astronomy Observatorys Karl G. Jansky Very Large Array, which took a star turn in the SETI movie Contact.

Were developing a system that will allow us to tap all of the data that the VLA produces and use it 24 hours a day, seven days a week to search for anomalies alongside other science, Siemion said.

If NRAO wins the go-ahead for a next-generation upgrade of the Jansky VLA, Breakthrough LIstens capability would be similarly upgraded.

This is the first radio telescope that would ever be built that would allow us to be sensitive to leakage radiation radio signals that are as weak as our isotropic emissions from the planet from a handful of nearby stars, Siemion said. In other words, it would theoretically be capable of picking up the signals coming from E.T.s smartphone on Proxima Centauri b.

Huge radio dishes arent the only instruments being used in the hunt for alien signals: Pioneer SETI astronomer Jill Tarter touted the development of a new type of wide-angle optical observatory, known as Panoramic SETI or PANOSETI, which would be capable of recording brief flashes of light. Such flashes may be associated with weird phenomena known as fast radio bursts, and theres a chance they might follow a pattern suggestive of intentional transmissions from a far-off civilization.

Two prototype PANOSETI telescopes are being tested at the Lick Observatorys Astrograph Dome in California. The plan calls for building two PANOSETI observatories, each with 80 telescopes arranged to cover the sky. If you get a pulse somewhere between a nanosecond and a second in duration, both observatories will see it, and you will be very confident of your result, Tarter explained.

Another long-running project at the SETI Institute, called LaserSETI, takes a different approach to the search for optical signals. LaserSETIs compact camera enclosures are designed to scan the entire sky for short blips of laser light, from as many as 15 sites around the world.

Since last August, the first two enclosures have been operating on the rooftop of the Robert Ferguson Observatory in Sonoma, California, Tarter said. The next two enclosures are going to be placed in Hawaii, at the Haleakala Observatory. And ultimately, well have something like this globally to look at all the sky, all the time, for transients.

Optical SETI could widen the search for alien signals to a whole new region of the electromagnetic spectrum, but theres an all-too-earthly obstacle to overcome.

Neither PANOSETI nor LaserSETI are fully funded, so we cant say when they might be complete, Tarter told the Seattle audience. If you have an opportunity to provide some funding, both of those projects would benefit from it.

As the acronym suggests, SETI looks for the characteristic patterns of intentional signals from beyond the solar system. But theres growing interest in the search for signs of less advanced life among the stars.

Were not looking for little green men, were looking for little green pond slime, said University of Washington astronomer Victoria Meadows, who heads UWs Virtual Planetary Laboratory.

In the decade ahead, NASAs James Webb Space Telescope could track down the first chemical signals of extraterrestrial life processes, perhaps through the detection of such gases as water vapor, methane and carbon dioxide in alien atmospheres. The next generation of ground-based telescopes could also contribute to the quest.

For now, the most promising nearby target for closer inspection is the TRAPPIST-1 system, which appears to have more than one potentially habitable planet. But Meadows warned that appearances can be deceiving. Computer simulations suggest that some seemingly habitable planets could have had their oceans cooked away early in the process of planetary evolution. Such planets turn out looking more like hellish Venus than habitable Earth.

If you think of the Earth as a kernel of corn, then Venus is like the popcorn of the solar system. Can we discriminate between a nice habitable planet, and one thats undergone ocean or atmospheric loss to be in the popcorn zone? Meadows said.

She said its likely to take more than the James Webb Space Telescope to nail down the chemical case for life beyond the solar system.

JWST will really give us a tantalizing glimpse that would be potentially habitable. Well get this tantalizing glimpse, but we wont get anything really definitive, Meadows said. To do that, we are going to need far more capable missions, and happily, NASA is currently considering them.

Several mission concepts with implications for astrobiology including HabEx, LUVOIR, Lynx and Origins are due to be assessed during a decadal survey of astronomical priorities.

Over the course of the next couple of decades, those new spacecraft should give astronomers a much better view of the heavens. But other types of new spacecraft are giving astronomers pause: Several companies including SpaceX, OneWeb, Telesat and Amazon are planning to put thousands of satellites in low Earth orbit to provide global broadband internet access. The satellites already launched by OneWeb and SpaceX have sparked concerns about radio interference, an issue that strikes at the heart of the traditional SETI quest.

If it happened that some civilization is transmitting in exactly one of the frequencies used by one of these companies, theres going to be a problem detecting it, NRAO Director Tony Beasley told GeekWire.

Beasley said he and other astronomers are involved in discussions with SpaceX to work out ways to minimize the potential harm, and hes hoping to have similar talks with OneWeb and the other satellite constellation companies. One of the measures being discussed would involve switching off the satellites for brief periods while they pass over sensitive radio dishes. Other measures could involve processing radio data to cancel out the satellites effects.

There are ways with our telescopes to be able to detect nearby moving objects and so we do have ways to separate them from celestial signals in some sense, Beasley said. But in general, a noisier environment just makes it harder to hear something.

If scientists do hear a confirmed signal from E.T., you can bet that the conflict over constellations would quickly fade away. So would the financial challenges that SETI astronomers currently face.

Ive been promised unlimited funding if we detect a signal, Breakthrough Listens Siemion said.

View post:

SETI and other alien-hunting strategies are dealing with new tools and new troubles - GeekWire

Watch out, Avengers: This asteroid has a more violent track record than Thanos – SYFY WIRE

When you hear the word asteroid, you probably think of something hurtling towardEarth at unfathomable speeds, ready to take us out like Thanos snapping his fingers but the asteroid Pallas has experienced violence in a whole other way.

Pallas is namedafter Pallas Athena. She was the ancient Greek goddess of wisdom, but what you might not know is that Athena was also a martial deity who was often portrayed with a helmet, shield, and spear. Pallas the asteroid looks like its been through endless cosmic battles, and all the impact craters punched into it say its really taken a beating. A strange orbit that takes it crashing through the asteroid belt is to blame. Now a research team led by Pierre Vernazza of the Laboratoire d'Astrophyisque de Marseille in France has been able to observe the asteroid like never before to reveal its violent history.

Just to give you an idea of what kind of chaos Pallas has been through, Vernazza and his team found 36 craters that exceeded 18 miles in diameter. Thats just a fifth of the diameter of the fateful Chicxulub asteroid that trashed the dinosaurs 65 million years ago.

Pallas is the largest main-belt object not yet visited by a spacecraft, making its surface geology largely unknown and limiting our understanding of its origin and collisional evolution, Vernazza and colleagues said in a study recently published in Nature Astronomy, explaining why they needed some help from computers here on Earth to start understanding it.

Pallas has a weirdly tilted orbit that has long been suspected, but finally studied using images of its pockmarked face from the Very Large Telescopes SPHERE instrument an array of four telescopessituated with 8-meter-wide mirrors that the team reserved for two years to see if they could catch Pallas orbiting as close to Earth as possible.

Vernazza and the other astronomers used the 11 images they were able to grab to generate a 3D reconstruction of what the asteroid should look like up close meaning its shape, its poles, and all its craters. The level of violence it had been through was gauged by its reputation for butting heads with everything else floating around in the asteroid belt over the past 4 billion years. Asteroids Ceres and Vesta were used as comparisons in simulations that showed every collision.

Pallas was found to have been bombarded with crashes that left behind craters on at least 10 percent of its surface, which the team said was suggestive of a violent collisional history. Something odd the team found about Pallas when compared to Ceres and Vesta was that it didnt take as much force to put a dent in Pallas. The same size of crater on either of the other two asteroids, about 25 miles in diameter, could be made by a much smaller object hitting Pallas at a high velocity. If you think about how many smaller objects are zooming through the asteroid belt compared to larger ones, you can probably imagine what Pallas goes through.

As if all that weren't enough, Pallas was also discovered to have a monster crater thought to be caused by its chemical composition, and a mysterious bright spot in its southern hemisphere whose origin remains unknown.

The Avengers dont have to put themselves at risk again to find out more but NASAmight send out satellites in the future.

(via Phys.org/Nature Astronomy)

Read this article:

Watch out, Avengers: This asteroid has a more violent track record than Thanos - SYFY WIRE

Genetic engineering company says they have created a coronavirus vaccine – 9News.com KUSA

HOUSTON A Houston-based genetic engineering company said it has a vaccine aimed at the deadly coronavirus outbreak, according to a report by the Houston Business Journal.

The genetic engineering firm, Greffex Inc. has one of its laboratories based in Aurora, Colorado.

RELATED: Coronavirus death toll hits 2,100 in mainland China

RELATED: Colorado man living in China posts brutally honest Instagram videos of coronavirus self-quarantine

John Price, president and CEO of Greffex Inc., told KHOU, our sister station in Houston, that Greffex's scientists completed the coronavirus vaccine this week.

The trick in making a vaccine is can you scale the vaccine that youve made to be able to make a certain number of doses, can you test the vaccine quickly and efficiently and then can you get it into patients and thats where we have an edge as well on the other companies that are out there," said Price. "And that has to do with speed and essential uniformity of how we make vaccines, so that drops the cost down.

Price said the vaccine will now move into a testing phase with the Food and Drug Administration.

The Houston Business Journal reported, in September 2019 Greffex received an $18.9 million contract from the National Institute of Health's National Institute for Allergy and Infectious Diseases to develop new treatments for infectious threats.

If the vaccine gets government approval, Price said his company plans to give it away for free to nations hit hard by the coronavirus outbreak.

SUGGESTED VIDEOS | Local stories from 9NEWS

Link:

Genetic engineering company says they have created a coronavirus vaccine - 9News.com KUSA

Building a ‘doomsday vault’ to save the kangaroo and koala from extinction – CNET

The road into Batlow is littered with the dead.

In the smoky, gray haze of the morning, it's hard to make out exactly what Matt Roberts' camera is capturing. Roberts, a photojournalist with the Australian Broadcasting Corporation, keeps his lens focused on the road as he rolls into the fire-ravaged town 55 miles west of Canberra, Australia's capital. At the asphalt's edge, blackened livestock carcasses lie motionless.

The grim scene, widely shared on social media, is emblematic of the impact the 2019-20 bushfire season has had on Australia's animal life. Some estimates suggest "many, many billions" of animals have been killed, populations of endemic insects could be crippled and, as ash washes into riverways, marine life will be severely impacted. The scale of the bushfires is so massive, scientists are unlikely to know the impact on wildlife for many years.

But even before bushfires roared across the country, Australia's unique native animals were in a dire fight for survival. Habitat destruction, invasive species, hunting and climate change have conspired against them. Populations of native fauna are plummeting or disappearing altogether, leaving Australia with an unenviable record: It has the highest rate of mammal extinctions in the world.

A large share of Australia's extinctions have involved marsupials -- the class of mammals that includes the nation's iconic kangaroos, wallabies, koalas and wombats. A century ago, the Tasmanian tiger still padded quietly through Australia's forests. The desert rat-kangaroo hopped across the clay pans of the outback, sheltering from the sun in dug-out nests.

Now they're gone.

Australia's 2019-20 bushfire season has been devastating for wildlife.

In a search for answers to the extinction crisis, researchers are turning to one lesser-known species, small enough to fit in the palm of your hand: the fat-tailed dunnart. The carnivorous mouse-like marsupial, no bigger than a golf ball and about as heavy as a toothbrush, has a tiny snout, dark, bulbous eyes and, unsurprisingly, a fat tail. It's Baby Yoda levels of adorable -- and it may be just as influential.

Mapping the dunnart's genome could help this little animal become the marsupial equivalent of the lab mouse -- a model organism scientists use to better understand biological processes, manipulate genes and test new approaches to treating disease. The ambitious project, driven by marsupial geneticist Andrew Pask and his team at the University of Melbourne over the last two years, will see scientists take advantage of incredible feats of genetic engineering, reprogramming cells at will.

It could even aid the creation of a frozen Noah's Ark of samples: a doomsday vault of marsupial cells, suspended in time, to preserve genetic diversity and help prevent further decline, bringing species back from the brink of extinction.

If that sounds far-fetched, it isn't. In fact, it's already happening.

Creating a reliable marsupial model organism is a long-held dream for Australian geneticists, stretching back to research pioneered by famed statistician Ronald Fisher in the mid-20th century. To understand why the model is so important, we need to look at the lab mouse, a staple of science laboratories for centuries.

"A lot of what we know about how genes work, and how genes work with each other, comes from the mouse," says Jenny Graves, a geneticist at La Trobe University in Victoria, Australia, who has worked with marsupials for five decades.

The mouse is an indispensable model organism that shares many genetic similarities with humans. It has been key in understanding basic human biology, testing new medicines and unraveling the mysteries of how our brains work. Mice form such a critical part of the scientific endeavor because they breed quickly, have large litters, and are cheap to house, feed and maintain.

The lab mouse has been indispensable in understanding physiology, biology and genetics.

In the 1970s, scientists developed a method to insert new genes into mice. After a decade of refinement, these genetically modified mice (known as "transgenic mice") provided novel ways to study how genes function. You could add a gene, turning its expression up to 11, or delete a gene entirely, shutting it off. Scientists had a powerful tool to discover which genes performed the critical work in reproduction, development and maturation.

The same capability does not exist for marsupials. "At the moment, we don't have any way of manipulating genes in a devil or a kangaroo or a possum," says Graves. Without this capability, it's difficult to answer more pointed questions about marsupial genes and how they compare with mammal genes, like those of mice and humans.

So far, two marsupial species -- the Tammar wallaby and the American opossum -- have been front and center of research efforts to create a reliable model organism, but they both pose problems. The wallaby breeds slowly, with only one baby every 18 months, and it requires vast swaths of land to maintain.

The short-tailed opossum might prove an even more complicated case. Pask, the marsupial geneticist, says the small South American marsupial is prone to eating its young, and breeding requires researchers to sift through hours of video footage, looking for who impregnated whom. Pask also makes a patriotic jab ("they're American so we don't like them") and says their differences from Australian marsupials make them less useful for the problems Australian species face.

But the dunnart boasts all the features that make the mouse such an attractive organism for study: It is small and easy to house, breeds well in captivity and has large litters.

"Our little guys are just like having a mouse basically, except they have a pouch," Pask says.

Pask (front) and Frankenberg inspect some of their dunnarts at the University of Melbourne.

A stern warning precedes my first meeting with Pask's colony of fat-tailed dunnarts.

"It smells like shit," he says. "They shit everywhere."

I quickly discover he's right. Upon entering the colony's dwellings on the third floor of the University of Melbourne's utilitarian BioSciences building, you're punched in the face by a musty, fecal smell.

Pask, a laid-back researcher whose face is almost permanently fixed with a smile, and one of his colleagues, researcher Stephen Frankenberg, appear unfazed by the odor. They've adapted to it. Inside the small room that houses the colony, storage-box-cages are stacked three shelves high. They're filled with upturned egg cartons and empty buckets, which work as makeshift nests for the critters to hide in.

Andrew Pask

Frankenberg reaches in without hesitation and plucks one from a cage -- nameless but numbered "29" -- and it hides in his enclosed fist before peeking out of the gap between his thumb and forefinger, snout pulsing. As I watch Frankenberg cradle it, the dunnart seems curious, and Pask warns me it's more than agile enough to manufacture a great escape.

In the wild, fat-tailed dunnarts are just as inquisitive and fleet-footed. Their range extends across most of southern and central Australia, and the most recent assessment of their population numbers shows they aren't suffering population declines in the same way many of Australia's bigger marsupial species are.

Move over, Baby Yoda.

As I watch 29 scamper up Frankenberg's arm, the physical similarities between it and a mouse are obvious. Pask explains that the dunnart's DNA is much more closely related to the Tasmanian devil, an endangered cat-sized carnivore native to Australia, than the mouse. But from a research perspective, Pask notes the similarities between mouse and dunnart run deep -- and that's why it's such an important critter.

"The dunnart is going to be our marsupial workhorse like the mouse is for placental mammals," Pask says.

For that to happen, Pask's team has to perfect an incredible feat of genetic engineering: They have to learn how to reprogram its cells.

To do so, they collect skin cells from the dunnart's ear or footpad and drop them in a flask where scientists can introduce new genes into the skin cell. The introduced genes are able to trick the adult cell, convincing it to become a "younger," specialized cell with almost unlimited potential.

The reprogrammed cells are known as "induced pluripotent stem cells," or iPS cells, and since Japanese scientists unraveled how to perform this incredible feat in 2006, they have proven to be indispensable for researchers because they can become any cell in the body.

"You can grow them in culture and put different sorts of differentiation factors on them and see if they can turn into nerve cells, muscle cells, brain cells, blood vessels," Pask explains. That means these special cells could even be programmed to become a sperm or an egg, in turn allowing embryos to be made.

Implanting the embryo in a surrogate mother could create a whole animal.

It took about 15 minutes to get this dunnart to sit still.

Although such a technological leap has been made in mice, it's still a long way from fruition for marsupials. At present, only the Tasmanian devil has had iPS cells created from skin, and no sperm or egg cells were produced.

Pask's team has been able to dupe the dunnart's cells into reverting to stem cells -- and they've even made some slight genetic tweaks in the lab. But that's just the first step.

He believes there are likely to be small differences between species, but if the methodology remains consistent and reproducible in other marsupials, scientists could begin to create iPS cells from Australia's array of unique fauna. They could even sample skin cells from wild marsupials and reprogram those.

Doing so would be indispensable in the creation of a biobank, where the cells would be frozen down to -196 degrees Celsius (-273F) and stored until they're needed. It would act as a safeguard -- a backup copy of genetic material that could, in some distant future, be used to bring species back from the edge of oblivion, helping repopulate them and restoring their genetic diversity.

Underneath San Diego Zoo's Beckman Center for Conservation Research lies the Frozen Zoo, a repository of test tubes containing the genetic material of over 10,000 species. Stacked in towers and chilled inside giant metal vats, the tubes contain the DNA of threatened species from around the world, suspended in time.

It's the largest wildlife biobank in the world.

"Our goal is to opportunistically collect cells ... on multiple individuals of as many species as we can, to provide a vast genetic resource for research and conservation efforts," explains Marlys Houck, curator at the Frozen Zoo.

The Zoo's efforts to save the northern white rhino from extinction have been well publicized. Other research groups have been able to create a northern white rhino embryo in the lab, combining eggs of the last two remaining females with frozen sperm from departed males. Scientists propose implanting those embryos in a surrogate mother of a closely related species, the southern white rhino, to help drag the species back from the edge of oblivion.

For the better part of a decade, conservationists have been focused on this goal, and now their work is paying off: In the "coming months," the lab-created northern white rhino embryo will be implanted in a surrogate.

Sudan, the last male northern white rhinoceros, was euthanized in 2018.

Marisa Korody, a conservation geneticist at the Frozen Zoo, stresses that this type of intervention was really the last hope for the rhino, a species whose population had already diminished to just eight individuals a decade ago.

"We only turn to these methods when more traditional conservation methods have failed," she says.

In Australia, researchers are telling whoever will listen that traditional conservation methods are failing.

"We've been saying for decades and decades, many of our species are on a slippery slope," says John Rodger, a marsupial conservationist at the University of Newcastle, Australia, and CEO of the Fauna Research Alliance, which has long advocated for the banking of genetic material of species in Australia and New Zealand.

In October, 240 of Australia's top scientists delivered a letter to the government detailing the country's woeful record on protecting species, citing the 1,800 plants and animals in danger of extinction, and the "weak" environmental laws which have been ineffective at keeping Australian fauna alive.

Institutions around Australia, such as Taronga Zoo and Monash University, have been biobanking samples since the '90s, reliant on philanthropic donations to stay online, but researchers say this is not enough. For at least a decade, they've been calling for the establishment of a national biobank to support Australia's threatened species.

John Rodger

"Our real problem in Australia ... is underinvestment," Rodger says. "You've got to accept this is not a short-term investment."

The current government installed a threatened-species commissioner in 2017 and committed $255 million ($171 million in US dollars) in funding to improve the prospects of 20 mammal species by 2020. In the most recent progress report, released in 2019, only eight of those 20 were identified as having an "improved trajectory," meaning populations were either increasing faster or declining slower compared to 2015.

A spokesperson for the commissioner outlined the $50 million investment to support immediate work to protect wildlife following the bushfires, speaking to monitoring programs, establishment of "insurance populations" and feral cat traps. No future strategies regarding biobanking were referenced.

Researchers believe we need to act now to preserve iconic Australian species like the koala.

In the wake of the catastrophic bushfire season and the challenges posed by climate change, Australia's extinction crisis is again in the spotlight. Koalas are plastered over social media with charred noses and bandaged skin. On the front page of newspapers, kangaroos bound in front of towering walls of flame.

Houck notes that San Diego's Frozen Zoo currently stores cell lines "from nearly 30 marsupial species, including koala, Tasmanian devil and kangaroo," but that's only one-tenth of the known marsupial species living in Australia today.

"Nobody in the world is seriously working on marsupials but us," Rodger says. "We've got a huge interest in maintaining these guys for tourism, national icons... you name it."

There's a creeping sense of dread in the researchers I talk to that perhaps we've passed a tipping point, not just in Australia, but across the world. "We are losing species at an alarming rate," says Korody from the Frozen Zoo. "Some species are going extinct before we even know they are there."

With such high stakes, Pask and his dunnarts are in a race against time. Perfecting the techniques to genetically engineer the tiny marsupial's cells will help enable the preservation of all marsupial species for generations to come, future-proofing them against natural disasters, disease, land-clearing and threats we may not even be able to predict right now.

Pask reasons "we owe it" to marsupials to develop these tools and, at the very least, biobank their cells if we can't prevent extinction. "We really should be investing in this stuff now," he says. He's optimistic.

In some distant future, years from now, a bundle of frozen stem cells might just bring the koala or the kangaroo back from the brink of extinction.

And for that, we'll have the dunnart to thank.

Originally published Feb. 18, 5 a.m. PT.

Read the original here:

Building a 'doomsday vault' to save the kangaroo and koala from extinction - CNET

Is the vaccine to thwart the new coronavirus stored in a Houston freezer? – Houston Chronicle

Scientists around the world are scrambling to develop a vaccine to stop the spread of the new coronavirus, but the best candidate might be an experimental one stored in a Houston freezer.

The vaccine, developed by researchers at Baylor College of Medicine and University of Texas Medical Branch at Galveston researchers, effectively protected mice against SARS, or severe acute respiratory syndrome, the pneumonia-causing virus from the same family that spread in the early 2000s. The vaccine never progressed to human testing because manufacturing of it wasnt completed until 2016, long after SARS had burned out.

It generated zero interest from pharmaceutical companies, said Peter Hotez, a Baylor vaccine researcher and infectious disease specialist. Because the virus was no longer circulating, their response was essentially, thanks, but no thanks.

Hotez thinks the vaccine-in-storage can provide cross-protection against the new coronavirus, now officially named COVID-19, whose spread through China and, increasingly, to other countries has the world on edge. The virus, first detected in Wuhan, China, has now infected more than 75,000 people and killed more than 2,200, more than the 774 deaths from SARS. Although the bulk of the cases and deaths have occurred in China, COVID-19 now has been confirmed in 28 countries, the U.S. among them.

On HoustonChronicle.com: Coronavirus fears weigh on Houston economy as oil prices fall, businesses lose customers

The 34 cases in the United States 21 repatriated individuals and 13 travelers who fell ill after returning include three in Texas, an American citizen who was part of a group evacuated from China on a State Department-chartered flight, and two citizens on the Diamond Princess cruise ship. All three were taken to Lackland Air Force Base in San Antonio.

The Baylor-UTMB vaccine looks promising for COVID-19 because the virus so resembles SARS Hotez calls it SARS-2 which circulated between November 2002 and July 2003, mostly in mainland China and Hong Kong but also in Toronto, whose economy was so badly wrought by the outbreak that it needed a boost from a benefit concert featuring the Rolling Stones, Justin Timberlake and others to help shake the effects.

COVID-19 shares 82 percent of its genes with SARS and infects people through the same cell receptor, one of the spike-like proteins that stud the surface of coronaviruses and gives the family their name. The viruses originally jump from animals to people.

###

The two coronaviruses, which have mostly resulted in deaths in the elderly and people with serious underlying conditions, both can cause a severe form of pneumonia characterized by fever, cough and breathing difficulties. The early thinking is that COVID-19 is less lethal than SARS but more contagious.

There is no licensed treatment or vaccine for either, just supportive care focused on the symptoms.

The hope that the Baylor-UTMB vaccine should provide at least some, if not full, protection has had Hotez working the telephone the last few weeks, pleading with pharmaceutical companies and federal scientific agencies to pony up the funding needed to move the vaccine into clinical testing. The vaccine is still a candidate for such testing because the team has tested its continuing usefulness every six months, when it removes a sample from the freezer.

It may require some tweaking, but its stable, said Dr. James LeDuc, director of the Galveston National Laboratory on the UTMB Galveston campus. Every virus is different, features some adaptations.

The laboratory, a high-security biocontainment facility for the study of exotic disease, recently received the live COVID-19, which it will use to test the vaccine in mice, to see whether the SARS vaccine protects against it. The labs researchers created mice engineered to replicate the human disease.

###

Funding for clinical trials remains the big hurdle. Even with the new coronavirus circulating, Hotez has found few nibbles from pharmaceutical companies beyond the request to keep them informed and the suggestion their interest would pick up if the new coronavirus becomes a seasonal infection, like the flu.

Instead, Hotez is pinning his hopes for clinical trial funding on two grant proposals one to the British government; and another to the Coalition for Epidemic Preparedness Innovations, an Oslo-based coalition of charities (the Bill and Melinda Gates Foundation is a sponsor) and governments that aims to derail epidemics by speeding up the development of vaccines.

The Baylor-UTMB venture is just one of the many ongoing efforts to halt the coronavirus epidemic. About 300 scientists dialed in remotely to a World Health Organization meeting last week to fast-track tests, drugs and vaccines to help slow the outbreak. UT-Austin scientists published a paper in Science on their creation of the first 3D atomic-scale map of the spike protein the part of the virus that attaches to and infects human cells that should provide a road map for better vaccine development.

At least eight initiatives to develop new vaccines have been announced, most of which use new technology, such as a type sometimes called genetic immunization, that is considered highly promising but has not yet led to licensure. One Houston firm, Greffex, said it has used genetic engineering to create a COVID-19 vaccine it will now take to animal testing.

Hotez said he thinks the Baylor-UTMB vaccine has an advantage because its already been successfully tested in animals and because its based on classic vaccine technology, the same technology used, for instance, in approved vaccines for Hepatitis B and the human papillomavirus. He said the less-than-perfect match should provide protection in the same way flu vaccines provide protection even though theyre typically from 100 percent matches.

###

In addition to repurposing the SARS vaccine, the Baylor-UTMB team is working to develop its own new vaccine targeting COVID-19. But Hotez acknowledged that work will take longer than the SARS vaccine. He said hes surprised Chinese officials havent reached out to him about testing the vaccine in China.

Baylors work is conducted through its Texas Childrens Hospital Center for Vaccine Development, whose mission involves fighting public health threats that affect people who live in poverty such as neglected tropical diseases and coronaviruses. It has made vaccines for neglected tropical diseases Chagas disease, schistosomiasis and hookworm, and the coronavirus MERS, or Middle East respiratory syndrome, the camel flu that originated in Saudi Arabia in 2012 and later was confirmed in South Korea. Unlike SARS, MERS does not resemble COVID-19.

On HoustonChronicle.com: Why Houston is uniquely situated to be better prepared for the coronavirus threat

But the question is, can any vaccine make it through clinical testing in time to make a difference in the fight against an emerging epidemic or pandemic?

LeDuc noted that there are no shortcuts to the testing required to prove vaccines are safe and effective in people, a process he acknowledges could take a year, during which time the disease may burn out.

Hotez said the only thing that might expedite testing is if the spread of the disease becomes dire, a sobering thought that some public health officials think is looking more and more likely as COVID-19 is diagnosed in more countries.

It is why Hotez laments the missed opportunities to develop and stockpile vaccines for SARS, MERS and even Zika, the mosquito-borne infection that emerged in 2014-2017 but then burned out.

Its like little kids soccer games where everyone just follows the ball, said Hotez. They all run to the ball when its one spot, then to the next spot where it goes and then the one after that. No one stays at the goal to play defense.

todd.ackerman@chron.com

Read the original:

Is the vaccine to thwart the new coronavirus stored in a Houston freezer? - Houston Chronicle

Coronavirus (COVID-19) update: Busting the myth by looking at the facts – The European Sting

Centers for Disease Control and Prevention. A digital illustration of the coronavirus shows the crown-like appearance of the virus. (UN News)

Finally, some good news about the new coronavirus pneumonia outbreak (COVID-19). According to Reuters, Chinas National Health Commission reported a substantial drop of 77% in new coronavirus cases last week, as the number of new cases in China dropped last Wednesday to 394 from 1,749 on the previous day. According to CNNs most recent report, indeed the coronavirus situation is currently stabilising in China.

In addition, researchers from the University of Queensland (UQ) in Australia have announced their major breakthrough in developing the first coronavirus vaccine. More good news comes from Texas, US, whereby an American genetic engineering company reports it has completed the development of a coronavirus vaccine. Other multinational drug companies like Sanofi and Janssen are entering the race of developing the vaccine. Moreover, Chinas Vice Science and Technology Minister Xu Nanping stated that China is starting trials on its coronavirus vaccine in a months time from now.

Is the coronavirus more deadly than Ebola, SARS, MERS? On the contrary, COVID-19 has the lowest fatality rate compared to other deadly viruses. According to the Royal Australian College of General Practitioners, while the new coronavirus pneumonia has a case fatality rate (CFR) of 2.65%, Ebola has a CFR as high as 50%, MERS has a CFR of 34.4% and SARS has a CFR of 14-15%. Hence, coronavirus shouldnt be compared even to the rest as the fatality rate is much lower. Unfortunately, the latter isnt stressed in the news headlines whatsoever, simply because fearmongering and sensationalism is something that other media do for a living. Also, factual data like the low fatality rate of COVID-19 would stop the panic and result in a more realistic approach to the coronavirus outbreak, which could lead pop media to lose pop readership.

Besides, the European Centre for Disease Prevention and Control, the official EU Agency, which provides daily updates on the coronavirus, clearly stipulates about today that the risk associated with COVID-19 infection for people from the EU/EEA and UK is currently considered to be low to moderate.

What is the real reason behind this overly exaggeration of the press about COVID-19?

Since the outbreak of coronavirus in December 2019 in Chinas Hubei province, the world has been witnessing an increase in coronavirus cases with approximately 80,000 people being infected around the world. Chinas government has already taken emergency measures to contain the expansion of the disease like controlling the movement of people in the Hubei province or building a new large hospital to treat the coronavirus cases in a matter of days.

Nevertheless, during the first two months of 2020 the world has been taking some exaggerated measures against China like cancelling/blocking flights to/from China which refer to both transfers of people and goods. And all that despite the fact that the World Health Organization has been adamant that such measures are not recommended.

In addition, the worlds press has been extremely critical over the strict isolation measures taken by China to confine the outbreak. They also blamed China for violating human rights. At the same time in Italy these days entire villages and towns in the northern part of the country are completely quarantined by the Italian government. Consequently, the latter shows that what China does for the Hubei province is nothing more than standard emergency prevention measure to be taken by a country.

Moreover, as a result of fearmongering by the media through the omission of facts like for example the low fatality rate of the coronavirus, people tend to have a racist approach against Chinese citizens who are living or traveling outside China. Isnt it utterly unfair though and absolutely wrong to assimilate the few dozens of thousands of coronavirus cases with the 1.4 billion population of a country?

As regards the coronavirus impact on the second biggest economy of the world, besides the opportunistic approach by many markets to capitalise on this emergency with hostility, it seems that the economy is not dearly affected as gamblers would hope. In particular, the Ambassador of China to the EU has been recently reassuring on the matter: With business activities deferred and demand for services reduced, there is some impact on the Chinese economy. Yet the impact is limited, short-term and manageable. The epidemic will not change the positive prospects of the Chinese economy in the long term, the huge market demand offered by the 1.4 billion Chinese people, nor Chinas commitment to reform and opening-up. There is no need for global investors to worry too much.

All in all, while the coronavirus is surely a new challenge for the world in 2020, it is much needed that the worlds media maintain a balanced approach, discussing the coronavirus outbreak objectively without tactically losing interest from positive evolutions and news like the vaccination development achievements, the low fatality rate of the disease or the drop in the cases in China or effective responses. The latter is necessary to avoid that people panic. Besides, WHO has established a specific website to inform people and media about the coronavirus, which is based on facts, a sine qua non for journalism as it should be.

Follow this link:

Coronavirus (COVID-19) update: Busting the myth by looking at the facts - The European Sting

Potential CAR T-cell Therapy Targeting ROR1 Seen to Clear Cancer… – Immuno-Oncology News

A potential newCAR T-cell therapy by Oncternal Therapeutics showed strong activity against leukemia in mice, completely eliminating cancer cells from major tissue reservoirs in four weeks and extending survival by at least two months, according to preclinical data.

The CAR T-cells also remained highly active after being injected into the animals, and could be detected in the blood at least three months later without showing signs of exhaustion.

These findings were recently presented in a poster, Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1 binding SCFV derived from the clinical stage mab cirmtuzumab, at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.

CAR T-cell therapyis a type ofimmunotherapyin which researchers collect a patientsT-cells immune cells with anti-cancer activity and engineer them to recognize and eliminate cancer cells. This is done by introducing a gene in the cells genome that codes for a man-made receptor called a chimeric antigen receptor, or CAR which recognizes and targets a specific cancer molecule.

Upon finishing the genetic engineering step, the CAR T-cells are expanded in the lab and then injected into the patients blood. Typically, only one injection is needed, as the CAR T-cells are intended to be a long-lived treatment. By deriving the CAR T-cells from the patient, chances are also less likely of an immune system reaction to the re-introduced cells.

Oncternals CAR T-cell product is designed to target the ROR1 protein, which is produced during development but not usually found in adult tissues, except in some blood cancers a characteristic that makes it an attractive therapy target.

The therapeutic potential of the ROR1 protein was identified by researchers at the UC San Diego School of Medicine, who also developed a monoclonal antibody, called cirmtuzumab, targeting this protein.

Cirmtuzumab has been deemed safe in blood cancer trials, leading researchers at UCSC with support from the California Institute for Regenerative Medicine (CIRM) to develop a CAR T-cell product that targeted ROR1 in the exact same location.

At the ASCO-SITC presentation, the researchers shared preclinical data demonstrating the effectiveness of the anti-ROR1 CAR T-cells. In the lab, they found the engineered cells were able to specifically locate and attack cells that expressed ROR1.

This led them to test these CAR T-cells in a mouse model of leukemia. Mice given the treatment survived for over 90 days, compared to an average of 21 days in a control group of mice given non-engineered T-cells from the same donor. Another control animal group received no therapy.

In the treated mice, leukemia cells were seen to clear from the bone marrow, kidney, and spleen four weeks after treatment administration. These CAR T-cells also remained with no signs of exhaustionin treated mice 90 or more days later.

We are encouraged by the preclinical results of this ROR1 CAR-T program and look forward to advancing it to clinical testing, initially for treating patients with hematological cancers, potentially in the fourth quarter of this year, James Breitmeyer, MD, PhD, the president and CEO of Oncternal, said in a press release.

It is exciting to see the potent preclinical activity of the ROR1 CAR-T cell therapy and its selectivity in targeting tumors, added Thomas Kipps, PhD, the lead researcher into ROR1 treatments at UCSD. Harnessing cirmtuzumabs specificity for ROR1 expressed on cancer cells has the potential to improve CAR-T efficacy and safety, and address the high unmet medical need for treating patients with aggressive cancers.

Cirmtuzumab is now being tested in clinical trials in people with advanced breast cancer and those with B-cell lymphoid cancers.

David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.

Total Posts: 392

Ins holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Cincias e Tecnologias and Instituto Gulbenkian de Cincia.Ins currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.

Continue reading here:

Potential CAR T-cell Therapy Targeting ROR1 Seen to Clear Cancer... - Immuno-Oncology News

$19.8B Synthetic Biology Market by Tools, Technology, Application and Region – Forecast to 2025 – Yahoo Finance

Dublin, Feb. 17, 2020 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.

This report analyzes the market for various synthetic biology market and their adoption patterns. It aims at estimating the market size and future growth potential of the synthetic biology market and its subsegments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology are likely to hamper the growth of this market.

The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period

Based on tools, the market has been segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno-nucleic acids, and synthetic cells. In 2019, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period.

This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.

The genome engineering segment is expected to grow at the highest CAGR during the forecast period

On the basis of technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology, bioinformatics technologies.

The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.

The industrial applications segment is expected to grow at the highest CAGR during the forecast period

Based on application, the synthetic biology market is segmented into medical, industrial, food & agricultural, and environmental applications. The industrial applications segment is expected to grow at the highest CAGR owing to the rising applications of synthetic biology in producing renewable energy, biomaterials & green chemicals, and enzymes.

The Asia Pacific is projected to witness the highest growth during the forecast period

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the synthetic biology market.

However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support.

Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights 4.1 Market Overview4.2 Asia Pacific: Market, By Application4.3 Market: Geographic Growth Opportunities4.4 Market, By Region (2018-2025)4.5 Market: Developed vs. Developing Markets

5 Market Overview 5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Wide Range of Applications of Synthetic Biology5.2.1.2 Rising R&D Funding and Growing Initiatives in Synthetic Biology5.2.1.3 Declining Cost of DNA Sequencing and Synthesizing5.2.1.4 Increasing Investments in the Market5.2.2 Restraints5.2.2.1 Biosafety, Biosecurity, and Ethical Concerns5.2.3 Opportunities5.2.3.1 Rising Need for Fuel Alternatives5.2.3.2 Increasing Demand for Protein Therapeutics and Personalized Medicine5.2.3.3 Increasing Research in Synthetic Drugs and Vaccines5.2.4 Challenges5.2.4.1 Standardization of Biological Parts

6 Synthetic Biology Market, By Tool 6.1 Introduction6.2 Oligonucleotides & Synthetic DNA6.2.1 Oligonucleotides and Synthetic Dna to Dominate the Market During the Forecast Period6.3 Enzymes6.3.1 Development of Enzymes has Helped in Evolving New Therapies for A Range of Diseases6.4 Cloning Technology Kits6.4.1 Need for the Creation of Artificial Dna Along With Their Assembly is Driving the Growth of the Segment6.5 Synthetic Cells6.5.1 Synthetic Cells Will Allow Tailoring Biologics and Its Adoption is Expected to Grow in the Coming Years6.6 Chassis Organisms6.6.1 Increasing Demand for Fossil Fuels is Likely to Propel the Demand for Chassis Organisms6.7 Xeno-Nucleic Acids6.7.1 Xnas are Increasingly Researched With the Growing Demand for Breakthrough Medicine

7 Synthetic Biology Market, By Technology 7.1 Introduction7.2 Gene Synthesis7.2.1 Gene Synthesis to Dominate the Market During the Forecast Period7.3 Genome Engineering7.3.1 Increasing Demand for Synthetic Dna and Genes is Expected to Drive Market Growth7.4 Sequencing7.4.1 Ngs Technology is Rapidly Becoming an Indispensable and Universal Tool for Biological Research7.5 Bioinformatics7.5.1 Use of Bioinformatics Technologies is Increasing With the Rising Need for Data Management and Curation7.6 Cloning7.6.1 Cloning Aids in Building New Genetic Modules/Pathways, Enabling Rapid Advances in Research Across Various Industries7.7 Site-Directed Mutagenesis7.7.1 Wide Applications in Genetic Engineering, Dna Assembly, and Cloning Technologies is Driving This Segment7.8 Measurement & Modeling7.8.1 Computational Modeling is Aiding the Growth of the Segment During the Forecast Period7.9 Microfluidics7.9.1 Droplet Microfluidics is Gaining Wide Recognition in the Field of Synthetic Biology7.1 Nanotechnology7.10.1 Convergence Between Synthetic Biology and Nanotechnologies Aid in Building Complex Bodies

8 Synthetic Biology Market, By Application 8.1 Introduction8.2 Medical Applications8.2.1 Pharmaceuticals8.2.1.1 In 2019, the Pharmaceuticals Segment Accounted for the Largest Share of the Medical Applications Market8.2.2 Drug Discovery and Therapeutics8.2.2.1 Cancer Detection & Diagnostics8.2.2.1.1 With Rising Investments for Cancer Research, the Market for Synthetic Biology is Expected to Grow for This Segment8.2.2.2 Other Drug Discovery and Therapeutic Applications8.2.3 Artificial Tissue & Tissue Regeneration8.2.3.1 Bio-Synthesis8.2.3.1.1 Bio-Synthesis is Dominating the Market With Its Increasing Adoption in Creating Artificial Genomes8.2.3.2 Stem Cell Regulation8.2.3.2.1 Use of Synthetic Biology in Stem Cell Regeneration and Reprogramming Somatic Cells is Expected to Drive Market Growth8.2.3.3 Other Artificial Tissue and Tissue Regeneration Applications8.3 Industrial Applications8.3.1 Biofuel and Renewable Energy8.3.1.1 Advantages of Using Genetically Engineered Organisms for the Synthetic Production of Biofuels is Driving Market Growth8.3.2 Industrial Enzymes8.3.2.1 Textile Industry8.3.2.1.1 Synthetic Biology is Being Applied in the Textile Industry to Replace Traditional Raw Materials8.3.2.2 Paper Industry8.3.2.2.1 Enzymes are Being Increasingly Used in the Pulp and Paper Industry8.3.2.3 Other Industries8.3.3 Biomaterials & Green Chemicals8.3.3.1 Silk-Based Proteins are A Type of Biomaterial Prepared Through Synthetic Biology8.4 Food & Agriculture8.4.1 Synthetic Biology Techniques are Applied in the Food and Agriculture Industry to Produce Metabolites, Health Products, and Processing Aids8.5 Environmental Applications8.5.1 Bioremediation8.5.1.1 Owing to the Growing Severity of Environmental Problems, It has Become Necessary to Develop Cost-Effective, On-Site Methods for Environmental Monitoring and Bioremediation8.5.2 Biosensing8.5.2.1 Biosensor Applications Commonly Make Use of Microalgae Owing to Their High Reproductive Rates and Ease of Culturing Due to Their Microscopic Size

9 Synthetic Biology Market, By Region 9.1 Introduction9.2 North America9.2.1 US9.2.1.1 The US Dominates the North American Market9.2.2 Canada9.2.2.1 Strong Research Infrastructure and Availability of Funding Will Support Market Growth9.3 Europe9.3.1 UK9.3.1.1 The UK Holds the Largest Share of the European Market9.3.2 Germany9.3.2.1 The Rapidly Growing Pharmaceutical Market is Expected to Drive Market Growth9.3.3 France9.3.3.1 Research Across All Industries is Strongly Supported By the Government9.3.4 Denmark9.3.4.1 Denmark has the Third-Largest Commercial Drug-Development Pipeline in Europe9.3.5 Switzerland9.3.5.1 Market Growth is Primarily Driven By the Well-Established Pharmaceutical & Biotechnology Industry in the Country9.3.6 Spain9.3.6.1 Spain has A Well-Established Network of Research Centers, Universities, and Hospitals, Which Form an Ideal Environment for Research9.3.7 Italy9.3.7.1 Growth in This Market is Mainly Driven By Increasing Life Science R&D in the Country, Funded By Both Public and Private Organizations9.3.8 Rest of Europe9.4 Asia Pacific9.4.1 Japan9.4.1.1 Large Number of Research Initiatives Towards the Development of Precision Medicine Supporting Market Growth9.4.2 China9.4.2.1 Growth in R&D to Enhance the Technological Capabilities in the Country, Thereby Driving the Demand for High-Quality Research Tools9.4.3 Australia9.4.3.1 Increasing Focus of the Healthcare System on Precision Medicine to Offer Significant Growth Opportunities9.4.4 India9.4.4.1 Increasing Pharma R&D and Government Funding in the Biotechnology Industry are the Major Factors Driving Market Growth9.4.5 Rest of Asia Pacific9.5 Latin America9.5.1 Strong Pharmaceutical Industry in the Region to Provide Significant Growth Opportunities9.6 Middle East and Africa9.6.1 Increasing Partnerships Among Global Players With Government Organizations in the Region to Support Growth

10 Competitive Landscape 10.1 Overview10.2 Market Share Analysis10.2.1 Synthetic Biology Market, By Key Players, 201810.3 Competitive Leadership Mapping10.3.1 Visionary Leaders10.3.2 Innovators10.3.3 Dynamic Differentiators10.3.4 Emerging Companies10.4 Competitive Situation and Trends10.4.1 Product Launches10.4.2 Expansions10.4.3 Acquisitions10.4.4 Other Strategies

11 Company Profiles 11.1 Thermo Fisher Scientific Inc.11.1.1 Business Overview11.1.2 Products Offered11.1.3 Recent Developments11.2 Merck KGaA11.3 Agilent Technologies Inc.11.4 Novozymes A/S11.5 Ginkgo Bioworks11.6 Amyris Inc.11.7 Intrexon Corporation11.8 Genscript Biotech Corporation11.9 Twist Bioscience11.10 Synthetic Genomics Inc. (SGI)11.11 Codexis Inc.11.12 Synthego Corporation11.13 Creative Enzymes11.14 Eurofins Scientific11.15 Cyrus Biotechnology Inc.11.16 Other Major Companies11.16.1 Atum11.16.2 Teselagen11.16.3 Arzeda11.16.4 Integrated DNA Technologies Inc.11.16.5 New England Biolabs

Story continues

For more information about this report visit https://www.researchandmarkets.com/r/sisouv

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Read this article:

$19.8B Synthetic Biology Market by Tools, Technology, Application and Region - Forecast to 2025 - Yahoo Finance

A Word That Everybody Hates | Bert Bigelow – Patheos

Google eugenics and you will find yourself buried under a mountain of different definitions. Some are fairly objective, but the vast majority disparage, even demonize, the idea. A few examples:

The study of how to arrange reproduction within a human population to increase the occurrence of heritable characteristics regarded as desirable. Developed largely by Sir Francis Galton as a method of improving the human race, eugenics was increasingly discredited as unscientific and racially biased during the 20th century, especially after the adoption of its doctrines by the Nazis in order to justify their treatment of Jews, disabled people, and other minority groups.

The study of or belief in the possibility of improving the qualities of the human species or a human population, especially by such means as discouraging reproduction by persons having genetic defects or presumed to have inheritable undesirable traits (negative eugenics) or encouraging reproduction by persons presumed to have inheritable desirable traits (positive eugenics).

A pseudoscience with the stated aim of improving the genetic constitution of the human species by selective breeding.

A writer of a recent article on another blog attacks Richard Dawkins for some statements he made about eugenics. Here is what Dawkins said:

Its one thing to deplore eugenics on ideological, political, moral grounds. Its quite another to conclude that it wouldnt work in practice. Of course it would. It works for cows, horses, pigs, dogs & roses. Why on earth wouldnt it work for humans? Facts ignore ideology.

For those determined to miss the point, I deplore the idea of a eugenic policy. I simply said deploring it doesnt mean it wouldnt work. Just as we breed cows to yield more milk, we could breed humans to run faster or jump higher. But heaven forbid that we should do it.

A eugenic policy would be bad. Im combating the illogical step from X would be bad to So X is impossible. It would work in the same sense as it works for cows. Lets fight it on moral grounds. Deny obvious scientific facts & we lose or at best derail the argument.

Even with his outspoken opposition to eugenics, he was excoriated, not only by the writer of the piece, but also by commenters. The final paragraph pretty much says it all:

Sorry, Dawkins, but whether eugenics worksand what it would even mean for it to workis actually an open question. Youre the one being unscientific, not your critics. Also, to say, in sum, Im not pro-eugenics, but it would work and anyone who says otherwise is an idiot, when in fact the jury is very much out on whether eugenics would workor even what that meansis weird.

A commentor says:

I think that any attempt to improve the human genome is very dangerous and perhaps existential in nature.

What if a couple, both blonde and blue-eyed, decide that they want a dark-haired, dark-eyed daughter? So, they have the genome in their fetus modified to make that happen. How is that an existential danger?

I acknowledge that I have moved the goalposts. The definitions I quoted above were based on earlier science, when genetic engineering was not possible. Now it is, although it is in an early stage of development, and many of the criticisms about unanticipated negative side-effects are valid. But Dawkins point was that science continues to advance, and saying that it will NEVER be possible is wrong.

Another commenter says:

The moral arguments against eugenics are profound.

How so? A religious believer might think that the design of a human being is the provenance of God, and usurping His authority is blasphemy, or even heresy. I dont share their beliefs, and see nothing fundamentally immoral about modifying a human genome. I recognize the dangers, and would not approve of it until there is reasonable assurance that no harm would result. But there is never a certainty of that, just as there is no certainty that if you get on an airplane, you will arrive at your destination safely. Life is full of risks.

The criticism of Dawkins for his comments is, in my opinion, unwarranted. He is a technologist. He understands the dangers and even said that he opposes eugenics. But that isnt enough to satisfy the defenders of Gods primacy in creating us according to His design. Or those who say that we will never be able to do it without risk. That is probably true, but who should decide what the risk vs. benefit ratio should be?

Continued here:

A Word That Everybody Hates | Bert Bigelow - Patheos

WHO: Therapeutic trial results against Covid-19 expected in three weeks – The Star Online

GENEVA/BEIJING (Xinhua): The World Health Organization (WHO) said Thursday (Feb 20) that preliminary results from clinical trials of therapeutics against the novel coronavirus (Covid-19) are expected in three weeks.

"We're also looking forward to results from two clinical trials of therapeutics prioritised by the WHO R&D Blueprint," WHO Director-General Tedros Adhanom Ghebreyesus said at a daily briefing.

In Beijing, a senior National Health Commission official said Friday that Chinese scientists are racing to develop vaccines by adopting five technological approaches.

The approaches include inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines, and vaccines using attenuated influenza virus as vectors.

Of the two WHO trials, one is the combination of two drugs for HIV, lopinavir and ritonavir, the other is testing an antiviral called remdesivir

"We expect preliminary results in three weeks," the WHO chief said.

Remdesivir is a drug developed by US pharmaceutical company Gilead Sciences. It has shown good antiviral activity against SARS and MERS coronavirus in previous cell and animal experiments.

It has also shown fairly good antiviral activity against the Covid-19 at the cellular level.

A randomised, double-blind, placebo-controlled clinical trial of remdesivir started on Feb 6 in several hospitals in the central Chinese city of Wuhan, and the trial will last until the end of April.

A study published in 2004 showed the anti-HIV drug combination of Lopinavir and Ritonavir has "substantial clinical benefit" when given to patients who had SARS.

The Wuhan Jinyintan Hospital, where the first 41 known patients were treated, has already launched a randomised, controlled trial of the anti-HIV drug combination, according to a report by Chinese researchers in the Lancet medical journal late last month.

The third version of Covid-19 treatment guidelines published by China's National Health Commission suggested that taking two Lopinavir/Ritonavir pills and inhaling a dose of nebulised alpha-interferon twice a day could benefit patients.

"Some projects have entered the stage of animal testing," Zeng Yixin, deputy director of National Health Commission, told a press conference on China's fight against the novel coronavirus outbreak.

"Under the premise of ensuring safety, effectiveness and accessibility (of vaccines), (we) foresee that as soon as from April to May this year some vaccines could enter clinical trials, or under specific conditions, could be applied for emergency use," Zeng said.

"Our goal is that if required by the outbreak situation, the emergency use of vaccines, as well as the emergency review and approval process, can be activated in accordance with laws," the official said. - Xinhua

Read the rest here:

WHO: Therapeutic trial results against Covid-19 expected in three weeks - The Star Online